Bone Biologics Stock Forecast

Sell candidate since Nov 04, 2025 Loss -19.05%

The Bone Biologics Corporation stock price gained 4.09% on the last trading day (Monday, 17th Nov 2025), rising from $1.56 to $1.63. During the last trading day the stock fluctuated 3.43% from a day low at $1.61 to a day high of $1.66. The price has fallen in 6 of the last 10 days and is down by -20.44% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 55 thousand more shares were traded than the day before. In total, 80 thousand shares were bought and sold for approximately $129.50 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.56 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.56% during the next 3 months and, with a 90% probability hold a price between $1.43 and $2.43 at the end of this 3-month period.

BBLG Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, November 14, 2025, and so far it has risen 4.09%. Further rise is indicated until a new top pivot has been found. Bone Biologics Corporation has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Bone Biologics Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.69 and $2.25. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Bone Biologics Corporation stock

Bone Biologics Corporation finds support from accumulated volume at $1.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0550 between high and low, or 3.43%. For the last week, the stock has had daily average volatility of 6.37%.

Bone Biologics Corporation is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BBLG) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Bone Biologics Corporation to open at $1.63, and during the day (based on 14 day Average True Range), to move between $1.56 and $1.69, which gives a possible trading interval of +/-$0.136 (+/-8.71%) up or down from last closing price. If Bone Biologics Corporation takes out the full calculated possible swing range there will be an estimated 8.71% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.56 (3.93%) than the resistance at $1.75 (7.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bone Biologics Corporation stock A Buy?

Bone Biologics Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.873 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $1.63 ( 0.225%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk